Semaglutide at a dose of 2.4 mg has established weight-loss and cardiovascular benefits, and cagrilintide at a dose of 2.4 mg ...

A new clinical trial found that taking a popular diabetes and weight-loss drug once weekly significantly improves blood sugar ...

A new clinical trial found that taking a popular diabetes and weight-loss drug once weekly significantly improves blood sugar ...

By Vijay Kumar Malesu An important international trial shows that combining cagrilintide and semaglutide helps adults with ...

Semaglutide improved time spent in glycemic range, time below rate and reduced body weight with low rates of hypoglycemia ...

Incidence rates of composite of death, MI, stroke were lower, but not significantly so, for patients treated with semaglutide ...

Semaglutide, known by popular brand names like Ozempic® and Wegovy®, has been making headlines lately. Initially, it was used to treat type 2 diabetes, but now it’s also getting attention for ...

Semaglutide, commonly known by its brand names Wegovy® and Ozempic®, has become a hot topic in the health and wellness world, especially for its weight loss benefits. Originally developed for ...

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. Drugs in this class mimic a hormone the human body produces that increases insulin production, lowers blood sugar and reduces hunger.

Tirzepatide and semaglutide are type 2 diabetes drugs often used for weight loss. Tirzepatide is less expensive and may be more effective. However, the drug is still new, and more research is needed.

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

Kidney disease treatment is undergoing a transformation, driven by exciting new research that reveals the protective power of semaglutide in patients with type 2 diabetes. Semaglutide, a ...